Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bacillus species, particularly Bacillus coagulans, have been investigated for their potential benefits in managing Irritable Bowel Syndrome (IBS). Some randomized controlled trials suggest that certain strains may help alleviate symptoms such as abdominal pain, bloating, and stool irregularities. The proposed mechanisms include modulation of gut microbiota, enhancement of gut barrier function, and immunomodulatory effects. Notably, a few studies have reported modest improvements in global IBS symptoms and quality of life measures in patients taking B. coagulans compared to placebo. However, the evidence base remains limited; most studies are small, short-term, and sometimes funded by manufacturers, raising concerns about bias and generalizability. Systematic reviews and meta-analyses generally conclude that while Bacillus-based probiotics may offer some benefit, the overall quality of evidence is low to moderate, and heterogeneity in strains, dosages, and study designs prevents firm conclusions. In summary, there is some scientific support—primarily for B. coagulans—but further large, independent, and well-controlled trials are needed before Bacillus probiotics can be strongly recommended for IBS treatment.

More about Bacillus
More about Irritable Bowel Syndrome

Other ingredients used for Irritable Bowel Syndrome

Other health conditions supported by Bacillus

Products containing Bacillus